{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:15:10Z","timestamp":1761765310508},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T00:00:00Z","timestamp":1275004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Febrile neutropenia carries a high risk of sepsis complications, and the identification of biomarkers capable to identify high risk patients is a great challenge. Angiopoietins (Ang -) are cytokines involved in the control microvascular permeability. It is accepted that Ang-1 expression maintains endothelial barrier integrity, and that Ang-2 acts as an antagonizing cytokine with barrier-disrupting functions in inflammatory situations. Ang-2 levels have been recently correlated with sepsis mortality in intensive care units.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We prospectively evaluated concentrations of Ang-1 and Ang-2 at different time-points during febrile neutropenia, and explored the diagnostic accuracy of these mediators as potential predictors of poor outcome in this clinical setting before the development of sepsis complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients that evolved with septic shock (n = 10) presented higher levels of Ang-2 measured 48 hours after fever onset, and of the Ang-2\/Ang-1 ratio at the time of fever onset compared to patients with non-complicated sepsis (n = 31). These levels correlated with sepsis severity scores.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our data suggest that imbalances in the concentrations of Ang-1 and Ang-2 are independent and early markers of the risk of developing septic shock and of sepsis mortality in febrile neutropenia, and larger studies are warranted to validate their clinical usefulness. Therapeutic strategies that manipulate this Ang-2\/Ang-1 imbalance can potentially offer new and promising treatments for sepsis in febrile neutropenia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-10-143","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T18:16:28Z","timestamp":1275070588000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Imbalances in serum angiopoietin concentrations are early predictors of septic shock development in patients with post chemotherapy febrile neutropenia"],"prefix":"10.1186","volume":"10","author":[{"given":"Brunna E","family":"Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silmara AL","family":"Montalvao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franciso JP","family":"Aranha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania FG","family":"Siegl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmino A","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lorand-Metze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce M","family":"Annichino-Bizzacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich V","family":"De Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,28]]},"reference":[{"issue":"6","key":"1123_CR1","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992, 101 (6): 1644-1655. 10.1378\/chest.101.6.1644.","journal-title":"Chest"},{"issue":"16","key":"1123_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348 (16): 1546-1554. 10.1056\/NEJMoa022139.","journal-title":"N Engl J Med"},{"issue":"2","key":"1123_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/ACO.0b013e328328d1a1","volume":"22","author":"D De Backer","year":"2009","unstructured":"De Backer D, Donadello K, Favory R: Link between coagulation abnormalities and microcirculatory dysfunction in critically ill patients. Curr Opin Anaesthesiol. 2009, 22 (2): 150-154. 10.1097\/ACO.0b013e328328d1a1.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"2","key":"1123_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 2003, 348 (2): 138-150. 10.1056\/NEJMra021333.","journal-title":"N Engl J Med"},{"issue":"13","key":"1123_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMsb020574","volume":"347","author":"HS Warren","year":"2002","unstructured":"Warren HS, Suffredini AF, Eichacker PQ, Munford RS: Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med. 2002, 347 (13): 1027-1030. 10.1056\/NEJMsb020574.","journal-title":"N Engl J Med"},{"issue":"6","key":"1123_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/cc2894","volume":"8","author":"PE Spronk","year":"2004","unstructured":"Spronk PE, Zandstra DF, Ince C: Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care. 2004, 8 (6): 462-468. 10.1186\/cc2894.","journal-title":"Crit Care"},{"issue":"6","key":"1123_CR7","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1084\/jem.20060375","volume":"203","author":"K Yano","year":"2006","unstructured":"Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, et al: Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006, 203 (6): 1447-1458. 10.1084\/jem.20060375.","journal-title":"J Exp Med"},{"issue":"2","key":"1123_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nm1351","volume":"12","author":"U Fiedler","year":"2006","unstructured":"Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, et al: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006, 12 (2): 235-239. 10.1038\/nm1351.","journal-title":"Nat Med"},{"issue":"5322","key":"1123_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997, 277 (5322): 55-60. 10.1126\/science.277.5322.55.","journal-title":"Science"},{"issue":"4","key":"1123_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/74725","volume":"6","author":"G Thurston","year":"2000","unstructured":"Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000, 6 (4): 460-463. 10.1038\/74725.","journal-title":"Nat Med"},{"issue":"6","key":"1123_CR11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/shk.0b013e318123867b","volume":"28","author":"JS Giuliano Jr","year":"2007","unstructured":"Giuliano JS, Lahni PM, Harmon K, Wong HR, Doughty LA, Carcillo JA, Zingarelli B, Sukhatme VP, Parikh SM, Wheeler DS: Admission angiopoietin levels in children with septic shock. Shock. 2007, 28 (6): 650-654.","journal-title":"Shock"},{"issue":"6","key":"1123_CR12","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1186\/cc7130","volume":"12","author":"P Kumpers","year":"2008","unstructured":"Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT: Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care. 2008, 12 (6): R147-10.1186\/cc7130.","journal-title":"Crit Care"},{"issue":"3","key":"1123_CR13","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/cc7866","volume":"13","author":"P Kumpers","year":"2009","unstructured":"Kumpers P, van Meurs M, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG: Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care. 2009, 13 (3): R64-10.1186\/cc7866.","journal-title":"Crit Care"},{"issue":"3","key":"1123_CR14","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","volume":"3","author":"SM Parikh","year":"2006","unstructured":"Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006, 3 (3): e46-10.1371\/journal.pmed.0030046.","journal-title":"PLoS Med"},{"issue":"4","key":"1123_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/SHK.0b013e318188bd06","volume":"31","author":"JM Siner","year":"2009","unstructured":"Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD: Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock. 2009, 31 (4): 348-353. 10.1097\/SHK.0b013e318188bd06.","journal-title":"Shock"},{"key":"1123_CR16","doi-asserted-by":"crossref","unstructured":"Herbst C, Naumann F, Kruse EB, Monsef I, Bohlius J, Schulz H, Engert A: Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy. Cochrane Database Syst Rev. 2009, CD007107-1","DOI":"10.1002\/14651858.CD007107.pub2"},{"issue":"2","key":"1123_CR17","first-page":"215","volume":"91","author":"H Cherif","year":"2006","unstructured":"Cherif H, Johansson E, Bjorkholm M, Kalin M: The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. Haematologica. 2006, 91 (2): 215-222.","journal-title":"Haematologica"},{"issue":"2","key":"1123_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/jinf.2001.0798","volume":"42","author":"I Malik","year":"2001","unstructured":"Malik I, Hussain M, Yousuf H: Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies. J Infect. 2001, 42 (2): 120-125. 10.1053\/jinf.2001.0798.","journal-title":"J Infect"},{"issue":"6","key":"1123_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, et al: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002, 34 (6): 730-751. 10.1086\/339215.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1123_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996, 22 (7): 707-710. 10.1007\/BF01709751.","journal-title":"Intensive Care Med"},{"issue":"16","key":"1123_CR21","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, et al: The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000, 18 (16): 3038-3051.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1123_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00520-004-0614-5","volume":"12","author":"A Uys","year":"2004","unstructured":"Uys A, Rapoport BL, Anderson R: Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer. 2004, 12 (8): 555-560. 10.1007\/s00520-004-0614-5.","journal-title":"Support Care Cancer"},{"key":"1123_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1196\/annals.1414.035","volume":"1138","author":"M Ellis","year":"2008","unstructured":"Ellis M: Febrile neutropenia. Ann N Y Acad Sci. 2008, 1138: 329-350. 10.1196\/annals.1414.035.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1123_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0008-6363(00)00281-9","volume":"49","author":"EM Conway","year":"2001","unstructured":"Conway EM, Collen D, Carmeliet P: Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001, 49 (3): 507-521. 10.1016\/S0008-6363(00)00281-9.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1123_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.CCM.0000251640.77679.D7","volume":"35","author":"SE Orfanos","year":"2007","unstructured":"Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, et al: Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med. 2007, 35 (1): 199-206. 10.1097\/01.CCM.0000251640.77679.D7.","journal-title":"Crit Care Med"},{"issue":"10","key":"1123_CR26","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/thx.2007.087387","volume":"63","author":"M van der Heijden","year":"2008","unstructured":"Heijden van der M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB: Angiopoietin-2, permeability oedema, occurrence and severity of ALI\/ARDS in septic and non-septic critically ill patients. Thorax. 2008, 63 (10): 903-909. 10.1136\/thx.2007.087387.","journal-title":"Thorax"},{"issue":"1","key":"1123_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/01.CIR.0000151287.08202.8E","volume":"111","author":"B Witzenbichler","year":"2005","unstructured":"Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C: Protective role of angiopoietin-1 in endotoxic shock. Circulation. 2005, 111 (1): 97-105. 10.1161\/01.CIR.0000151287.08202.8E.","journal-title":"Circulation"},{"issue":"11","key":"1123_CR28","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1111\/j.1538-7836.2007.02743.x","volume":"5","author":"JA Kremer Hovinga","year":"2007","unstructured":"Kremer Hovinga JA, Zeerleder S, Kessler P, Romani de Wit T, van Mourik JA, Hack CE, ten Cate H, Reitsma PH, Wuillemin WA, Lammle B: ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. J Thromb Haemost. 2007, 5 (11): 2284-2290. 10.1111\/j.1538-7836.2007.02743.x.","journal-title":"J Thromb Haemost"},{"issue":"5 Suppl","key":"1123_CR29","doi-asserted-by":"publisher","first-page":"S302","DOI":"10.1097\/00003246-200205001-00021","volume":"30","author":"K Reinhart","year":"2002","unstructured":"Reinhart K, Bayer O, Brunkhorst F, Meisner M: Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med. 2002, 30 (5 Suppl): S302-312. 10.1097\/00003246-200205001-00021.","journal-title":"Crit Care Med"},{"issue":"11","key":"1123_CR30","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","volume":"103","author":"U Fiedler","year":"2004","unstructured":"Fiedler U, Scharpfenecker M, Koidl S, Hegen A, Grunow V, Schmidt JM, Kriz W, Thurston G, Augustin HG: The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood. 2004, 103 (11): 4150-4156. 10.1182\/blood-2003-10-3685.","journal-title":"Blood"},{"issue":"7336","key":"1123_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/bmj.324.7336.539","volume":"324","author":"DL Sackett","year":"2002","unstructured":"Sackett DL, Haynes RB: The architecture of diagnostic research. BMJ. 2002, 324 (7336): 539-541. 10.1136\/bmj.324.7336.539.","journal-title":"BMJ"},{"issue":"6","key":"1123_CR32","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE: Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007, 165 (6): 710-718. 10.1093\/aje\/kwk052.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-143\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:13:16Z","timestamp":1630469596000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,28]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-143","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,28]]},"assertion":[{"value":"29 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"143"}}